S2 Part 1: Processing and minor processing

Published Date: 16 Feb 2023

Dr. Jacob Sands and Dr. Jared Weiss talk about subtypes. ongoing clinical trials; sustained sustained response to treatment; And it is possible to use the word "cure" to treat a small breast cancer.

Read Full News

Latest News

The Half-Life of Medical Certainty

Medical knowledge is always evolving. For his 100th column, Dr Kenny Lin reflects on how his views on cancer screening, blood pressure, and health policy have changed.

Infographic: How Much a Doctor’s Average Pay in the US Rose

On average, a physician in the US earned 3% more in 2025, a Medscape survey found. There was no major difference in compensation gains for primary care doctors vs specialists.

Early Multimodal Therapy Restores Hairline in a Woman

A 36-year-old woman with a 2-year history of hairline recession and eyebrow thinning shows marked regrowth after early multimodal therapy with dutasteride, tofacitinib, and intralesional steroids.

Man With Spinal Compression From Hepatocellular Carcinoma

The cervical biopsy was nondiagnostic despite imaging and PET suggesting aggressive disease; a targeted lumbar biopsy ultimately confirmed metastatic hepatocellular carcinoma.

From Pixels to Prescriptions: AI in Oncology Pathology

Digital pathology AI is moving from detection to treatment decisions. In part 2 of this series, here’s what’s FDA-cleared — and how it changes care in oncology practice.

Woman With Lateral Neck Cyst From Fourth Branchial Cleft

An uncommon congenital fourth branchial cleft cyst presents after exercise as a painless, mobile posterior neck mass, highlighting the need for prompt imaging and surgery.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Latest News

Medical knowledge is always evolving. For his 100th column, Dr Kenny Lin reflects on how his views on cancer screening, blood pressure, and health policy have changed.

On average, a physician in the US earned 3% more in 2025, a Medscape survey found. There was no major difference in compensation gains for primary care doctors vs specialists.

A 36-year-old woman with a 2-year history of hairline recession and eyebrow thinning shows marked regrowth after early multimodal therapy with dutasteride, tofacitinib, and intralesional steroids.

The cervical biopsy was nondiagnostic despite imaging and PET suggesting aggressive disease; a targeted lumbar biopsy ultimately confirmed metastatic hepatocellular carcinoma.

Digital pathology AI is moving from detection to treatment decisions. In part 2 of this series, here’s what’s FDA-cleared — and how it changes care in oncology practice.

An uncommon congenital fourth branchial cleft cyst presents after exercise as a painless, mobile posterior neck mass, highlighting the need for prompt imaging and surgery.

News All Time

Chest Plaque Reveals Dermatofibrosarcoma in a Man

Dermatofibrosarcoma protuberans can masquerade as a benign plaque — this case requires biopsy of a 10 × 8 cm anterior chest lesion to confirm spindle cell sarcoma and guide curative surgical excision.

New ‘Breathing’ Lung-On-Chip Surprises Against Tuberculosis

Four types of lung cells — including immune cells — function together on a chip environment that simulates respiration and inhibits tuberculosis growth.

S2 Episode 6: PCR in Breast Cancer and HER2

Drs Kathy Miller and Lajos Pusztai discuss predicting which patients will have a PCR, and the impact this has on new treatments or reducing the intensity of treatments.

Therapeutic Drug Monitoring Widely Variable in Ped Rheum

In a survey, pediatric rheumatologists cite a lack of training, lack of data, turnaround time, and lab timing as barriers to broader use.

Treat the Patient, Not the Biomarker: The ctDNA Dilemma

Professor David Kerr warns against 'treating the marker' in CRC. Should rising ctDNA trigger chemo without radiologic proof?

Stress Doesn’t Cause Cancer

The mistaken belief that stress can cause cancer leads many affected individuals to blame themselves for their cancer.

Mar 20 2026 This Week in Cardiology

Listener feedback, the huge CLOSURE-AF trial of LAAC vs best medical therapy, previews of CHAMPION AF, and the controversial ACC/AHA lipid treatment guidelines are the topics John Mandrola, MD, discusses in this week's podcast.

Insights in Renal Cell Carcinoma From ASCO GU 2026

Clinically significant developments in RCC presented at ASCO GU, including insights into the growing importance of HIF-2α inhibition, are discussed by Dr Brian Rini of Vanderbilt University.

Quantifying Cardiac Amyloid Burden

A standardized metric to quantify amyloid burden has yet to be established. Could extracellular volume assessments help track ATTR-CM disease status.

A 2-Year-Old Girl With a Single Pink “Bump” on Her Abdomen

The bump had been present for about 3 months. The patient’s mother said there had been no bleeding, tenderness, color change, rapid growth, or preceding trauma.

Rules for Thee, Not for Me: Neuroscience & Double Standards

With respect to the so-called ‘moral compass’, humans invariably judge others more harshly than they judge themselves.

ACC 2026: Anticipating New Data in Amyloid and ATTR-CM

Dr Kevin M. Alexander prepares for updates on amyloid research, real-world evidence, and imaging biomarkers.

EoE on the Rise: What Every Endoscopist Should Know

Dr David Johnson highlights the recommendations most likely to change how you endoscopically manage this increasingly prevalent disease.

What the 'Relax Your Tight End' Super Bowl Ad Got Wrong

PSA tests are never 'simple.' Dr Kenny Lin discusses how to move beyond overdiagnosis toward truly informed prostate cancer screening.

Staying the Course After EGFR Progression

Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond progression.

Recommended News For You

Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study

FDA Expands Approval of Osimertinib in Lung Cancer

In breast cancer patients with nodes positive, preoperative hydroxyprogesterone may enhance disease-free survival.

La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.

Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma

Adjuvant Tx May Boost Survival in Bilateral Breast Cancer

Could the Prostate Cancer Story of Francis Collins Dissuade Men from Active Surveillance?

Recommended Articles For You

KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer 

Understanding SVR Normal Range: A Guide to Achieving Optimal Health 

Cemiplimab: A Revolutionary Drug For Treating Cancer 

Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

2.

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

3.

Encounters matter in cancer care: Health care professionals can play a key role in restoring patients' sense of control

4.

Cancer care crowdfunding increasingly common, but rarely successful

5.

Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics

1.

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System

2.

Unlocking the Secrets of Blood Production: The Journey and Regulation of Hematopoietic Stem Cells

3.

CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights

4.

Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management

5.

Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Updates on the First Line Management of ALK+ NSCLC

2.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

4.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

5.

Navigating the Complexities of Ph Negative ALL - Part XII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot